CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER
https://doi.org/10.17650/2222-1468-2017-7-2-25-29
Abstract
Introduction. Cancer of the oral cavity comprises 6 % of all malignant tumors. Recurrences occur in 15–30 % of patients, 50 % have local recurrences, 25–30 % – regional. The choice of treatment depends on the location and stage of the recurrence.
Objective. To choose optimal tactics for surgical treatment in patients with recurrent cancer of the oropharyngeal region.
Materials and methods. The study included 314 patients with recurrent squamous cell carcinoma of the oropharyngeal region, who were treated at the N.N. Blokhin Russian Cancer Research Center and underwent surgical, combination, or conservative treatment.
Results. Survival in respect to the time of relapse was 35,0 ± 2.0 % for early (in the course of a year) relapses and 63,0 ± 7.1 % for late (a year after treatment and longer) relapses. Five-year survival in respect to the type of treatment for early recurrences was 34.2 ± 6 % for surgical treatment, 7.7 ± 3.5 % for combination treatment, and 17.6 ± 4.6 % for conservative approach. For late relapses, it was 62.7 ± 5.9 %, 77.8 ± 10.6 %, and 59.2 ± 8.7 %, respectively. Surgical treatment was performed in the form of removal of recurrent tumors, resection and reconstruction using local flaps, extended combined surgeries, and laser or cryodestruction.
Conclusion. The method of choice for treatment of recurrent tumors of oropharyngeal cancer is surgery in the form of an extended combined surgery with defect reconstruction using musculocutaneous flaps including the pectoralis major.
About the Authors
I. A. ZaderenkoRussian Federation
Surgical Department No. 11 for Tumors of the Upper Respiratory and Digestive Tracts of the Research Institute of Clinical Oncology.
23 Kashirskoe Shosse, Moscow 115478
A. M. Mudunov
Russian Federation
Surgical Department No. 11 for Tumors of the Upper Respiratory and Digestive Tracts of the Research Institute of Clinical Oncology.
23 Kashirskoe Shosse, Moscow 115478
S. B. Alieva
Russian Federation
Department of Radiation Oncology of the Research Institute of Clinical and Experimental Radiology.
23 Kashirskoe Shosse, Moscow 115478
A. A. Ahundov
Russian Federation
Surgical Department No. 11 for Tumors of the Upper Respiratory and Digestive Tracts of the Research Institute of Clinical Oncology.
23 Kashirskoe Shosse, Moscow 115478
References
1. Пачес А.И. Опухоли головы и шеи. Клиническое руководство. М.: Практическая медицина, 2013. [Paches А.I. Head and neck tumors. Clinical guidelines. Мoscow: Prakticheskaya meditsina, 2013. (In Russ.)].
2. Реконструктивные операции при опухолях головы и шеи. Под ред. Е.Г. Матякина. М.: Практическая медицина, 2009. [Reconstructive surgeries in head and neck tumors. Ed. E.G. Matyakin. Moscow: Prakticheskaya meditsina, 2009. (In Russ.)].
3. Mehanna H.M., Kian Ang K. Head and neck cancer recurrence: Evidence-based, Multidisciplinary management. 1st ed. Thieme, 2012. ISBN9783131645715.
4. Genden E.M., Ferlito A., Silver C.E. et al. Contemporary management of cancer of the oral cavity. Eur Arch Otorhinolaryngol 2010:267 (7):1001–7. DOI: 10.1007/s00405-010-1206-2. PMID: 20155361.
5. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований. Евразийский онкологический журнал 2014;4:692–879. [Davydov M.I., Aksel E.M. Statistics of malignant tumors. Evraziyskiy onkologicheskiy zhurnal = Euroasian Journal of Oncology 2014;4:692–879. (In Russ.)].
6. Agrawal A., Hammond T.H., Young G.S. et al. Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance. Laryngoscope 2009;119(11):2135–40. DOI: 10.1002/lary.20527. PMID: 19507214.
7. Agra I.M., Carvalho A.L., Ulbrich F.S. et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head and neck 2006;31(5);593–603. DOI: 10.1002/hed.20309. PMID: 16388526.
8. Lee S.C., Shores C.G., Weissler M.C. Salvage surgery after failed primary concomitant chemoradiation. Curr Opin Otolaryngol Head Neck Surg 2008;16(2):135–40. DOI: 10.1097/MOO.0b013e3282f495b6. PMID: 18327032.
9. Sklenicka S., Gardiner S., Dierks E.J. et al. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome? J Oral Maxillofac Surg 2010;68(6):1270–5. DOI: 10.1016/j.joms.2009.11.016. PMID: 20347201.
10. Задеренко И.А. Рецидивы плоскоклеточного рака слизистой оболочки полости рта и ротоглотки после радикального лечения. Клиника, диагностика, лечение. Автореф. … дис. д-ра мед. наук. М., 2014. Доступно по: http://medical-diss.com/medicina/retsidivy-ploskokletochnogo-raka-slizistoy-obolochki-polosti-rta-i-rotoglotki-posle-radikalnogo-lecheniya-klinika-diagnos. [Zaderenko I.A. Recurrences of squamous cell carcinoma of the oral and oropharyngeal mucosa after radical treatment. M. D. dissertation summary. Moscow, 2014. Available at: http://medical-diss.com/medicina/retsidivy-ploskokletochnogo-raka-slizistoy-obolochki-polosti-rta-i-rotoglotki-posle-radikalnogo-lecheniyaklinika-diagnos. (In Russ.)].
Review
For citations:
Zaderenko I.A., Mudunov A.M., Alieva S.B., Ahundov A.A. CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER. Head and Neck Tumors (HNT). 2017;7(2):25-29. (In Russ.) https://doi.org/10.17650/2222-1468-2017-7-2-25-29